Ballast Water, Living Oceans: Making Ongoing D-2 Compliance Work in Practice

The framework developed in stages — and the emphasis has moved

The Ballast Water Management Convention was adopted in 2004 and entered into force on 8 September 2017. The D-2 phase-in timetable for existing ships subject to the standard ran to 8 September 2024. The industry's focus has consequently moved from completing installations to maintaining effective treatment in operation.¹

The BWMS Code strengthened type approval in 2018. IMO's commissioning guidance then addressed the installed system: whether its mechanical, physical, chemical and biological processes functioned correctly. The 2020 revision explicitly separated representative sample collection and analysis from the manufacturer or supplier, and resolution MEPC.325(75) made commissioning testing mandatory for surveys completed on or after 1 June 2022.³

Independence adds confidence without diminishing the manufacturer's contribution. Equipment expertise remains essential to understanding an unexpected result, identifying an installation or operating issue, and implementing the right corrective action.

MEPC 84: where the amendments stand

As of 9 September 2026 the amendments are approved, not adopted. Adoption is scheduled for MEPC 85, which meets from 30 November to 3 December 2026. The entry-into-force date will be fixed at adoption; the class and industry expectation is 2028.^4,5

The draft separately addresses annual maintenance verification and, where applicable, annual residual-active-substance sampling. It does not establish a universal annual full D-2 biological test that is already in effect. MEPC 84 also amends regulation D-2 so that a BWMS using active substances must not discharge above its Maximum Allowable Discharge Concentration (MADC) — which is not one universal IMO limit, but a system-specific value to be read from the vessel's type approval certificate, IMO final approval documentation and the manufacturer's OMSM.⁹

MEPC 84 also adopted the revised 2026 G4 Guidelines on ballast water management plans (resolution MEPC.409(84)), which require plans to set out detailed contingency procedures and ship-specific measures for challenging water quality; their application is tied to the entry into force of the amended Convention. The direction of travel is consistent: owners will be expected to show that the system works, not only that it was fitted.⁴

Indicative and detailed analysis: different roles, one objective

Indicative analysis offers a relatively rapid assessment. Detailed analysis provides the stronger quantitative basis needed for a robust comparison of viable-organism concentrations with D-2. The distinction concerns the method and its analytical confidence — not simply a portable instrument versus a shore laboratory.²

Indicative testing already has a defined regulatory role. The standard IMO commissioning procedure specifies the two organism-size categories — ≥50 µm, and ≥10 µm to <50 µm — together with relevant self-monitoring checks. These are size categories, not a phytoplankton-only test. The full D-2 standard also retains its indicator-microbe limits, although those three microbial determinations are not part of the standard two-category commissioning procedure.^1,2

VMS provides prompt indicative testing using approaches referenced in IMO BWM.2/Circ.42/Rev.2, with the scope agreed for the vessel and purpose. Our service also includes detailed analysis, so the next analytical step can follow the question that needs answering.^2,9

For routine due diligence, timely indicative checks make biological verification part of normal fleet management. Detailed work adds value at planned verification opportunities, when results need clarification, and whenever the applicable authority or agreed assessment requires it. Each level of evidence has a job; neither should be asked to prove more than its method and sample can support.

What the D-2 limit actually looks like in the bottle

The D-2 standard expresses a very low concentration of organisms. That has a practical consequence which is easy to miss when a report is read as a single number: for the larger size class, the whole analysis turns on a handful of organisms.

Take the recommended sample volumes. EMSA's guidance recommends filtering and concentrating 300 to 450 litres for the ≥50 µm class, a continuous drip sample of about 5 litres — sub-sampled at 60 to 100 mL — for the ≥10 to <50 µm class, and about 1 litre for the bacterial standard.⁶ Published commissioning practice is comparable: two samples of 350 to 500 litres for the larger class, and the entire sample volume examined under a stereo-microscope.⁷

The ≥50 µm row is the one to sit with. At exactly the limit, 300 to 450 litres of ballast water contains around three to four and a half viable organisms. One organism found or missed shifts the reported concentration by 2.2 to 3.3 organisms per cubic metre, against a limit of 10 per cubic metre. IMO makes the same point in statistical terms: organism counts of this kind follow a Poisson distribution, so the sampling error and the analytical error have to be added together before a result is used to judge compliance.²

• It is a counting problem, not a reading problem. A ≥50 µm result is resolved in steps of roughly two to three organisms per m³. Reporting it to one decimal place implies a precision the method does not have.
• The two size classes are not comparable exercises. The smaller class puts hundreds of organisms in front of the analyst; the larger class puts a handful. They fail — and are misread — in different ways.
• Volume is evidence. If a report does not state the volume filtered and the volume examined, the count cannot be converted into a defensible concentration.

The laboratory question: accreditation for the right work

“ISO 17025 accredited” is an important starting point — but it is not a complete specification for detailed ballast-water analysis. ISO/IEC 17025:2017 establishes the laboratory-competence framework. The scope of accreditation should cover the relevant biological tests and methods.⁸

Recognised references for plankton analysis include APHA 10200 F and APHA 10200 G, from Standard Methods for the Examination of Water and Wastewater. These methods help define the biological testing capability to be checked within the laboratory's accredited scope.⁸

The distinction matters commercially as well as technically. An accredited metals or general water-chemistry service is not the same scope as accredited plankton analysis. Before placing detailed biological work, owners should be able to identify the relevant method, water matrix and activity in the laboratory's schedule — not rely on the accreditation logo alone.^2,8

The laboratory and the vessel must share a workable timetable

Detailed analysis is valuable, but its scientific strength depends on more than the method selected. IMO's BWM.2/Circ.42/Rev.2 explicitly recognises that the mode and duration of sample shipment can impair organism viability, while linking laboratory competence and uncertainty to ISO 17025.²

Consider a vessel with a short port stay and a narrow discharge window. The right analyst, equipment and sample-processing capacity must be available when the discharge sample can be collected. A nearby laboratory is useful only if it can receive and process that sample within the method's requirements.

The permissible interval from collection to processing or analysis is not the laboratory's report-turnaround time. Nor is it the treatment system's required contact or holding time before discharge. Sampling and transport must protect the measurement, with method-specific handling conditions and chain-of-custody records.⁶

Geography compounds the problem. Across the VMS port network of roughly 317 ports, most environmental sampling services are available at 240 to 260 of them — but IMO D-2 performance testing is available at fewer, precisely because it depends on specific laboratory capability. That gap is the practical reason a D-2 sampling plan is built around a shortlist of ports rather than around whichever call happens to be next.⁹

That is why regular onboard indicative testing and carefully scheduled detailed analysis are complementary. Rapid assessment reduces dependence on moving live samples over long distances. Detailed analysis can then be arranged at suitable ports — or with appropriately mobilised capability — without asking sample biology to accommodate a doubtful transport plan.

Where detailed analysis is required, logistical difficulty is not a waiver. The response is to arrange the necessary capability or a suitable sampling opportunity in advance. A delayed or compromised sample should not be treated as adequate merely because the selected analytical method is well recognised.

How VMS brings the process together

A continuing programme — not an isolated pass or fail

VMS recommends regular indicative checks at intervals informed by trading pattern, treatment-system history and operating risk, with additional attention after significant repairs or unexplained performance concerns. This is a due-diligence recommendation; IMO does not yet impose a routine biological-testing calendar on every ship.

Build detailed analysis into suitable port calls rather than treating it only as an emergency response. Where practicable, paired indicative and detailed assessments can help owners, laboratories and manufacturers understand how their monitoring performs under real operating conditions.

For adverse, borderline or unexplained findings, review both sample quality and system operation. Apply the vessel's relevant contingency and reporting procedures, involve the manufacturer where needed, and document corrective action and verification. A later favourable result should not leave an earlier concern unresolved.

1. 01
   Question 01

   Is the accredited scope the right scope?

   Find the plankton methods, the water matrix and the viability determination in the laboratory’s schedule of accreditation — not the logo on the report.

2. 02
   Question 02

   Does the count answer the D-2 question?

   Confirm how viable organisms are distinguished, how the size boundaries are applied, what volume was examined and what the reporting limit and uncertainty are.

3. 03
   Question 03

   Can the real itinerary meet the viability clock?

   Map collection, processing, handover and analysis against the vessel’s actual window — the ≥50 µm count is measured in hours, not days.

4. 04
   Question 04

   Will the sample history withstand review?

   Agree what will be recorded, how deviations are reported, and when qualification or resampling becomes necessary.

The opportunity for the industry is a better exchange of evidence: measurements that crews can act on, operational feedback that manufacturers can use, and reports whose methods and limitations are clear to the authorities reviewing them. Periodic tests cannot prove every discharge continuously, but a well-designed programme can make performance less dependent on assumption.